SCHEMBL28010784

SCHEMBL28010784

COc1cccc(-n2nc(OS(=O)(=O)C(F)(F)F)cc2-c2ccc(Cl)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.50
PTGS1 P23219 6/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
TSHR P16473 1/20 0.50
CYP2C19 P33261 1/20 0.50
THPO P40225 1/20 0.50
BLM P54132 1/20 0.50
PMP22 Q01453 1/20 0.50
HIF1A Q16665 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
CCKAR P32238 2/20 0.46
CACNB4 O00305 1/20 0.45
CACNA1A O00555 1/20 0.45
CACNA1G O43497 1/20 0.45
CACNG3 O60359 1/20 0.45
CACNA1F O60840 1/20 0.45
CACNA1H O95180 1/20 0.45
CACNB3 P54284 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15569210 0.81 CACNB4 (0.66) CACNB4CACNA1ACACNA1GCACNG3CACNA1F
SCHEMBL5147723 0.78 PTGS2 (0.58) PTGS2PTGS1CYP1A2CYP3A4CYP2C9
SCHEMBL5150244 0.75 PTGS2 (0.58) PTGS2PTGS1CYP1A2CYP3A4CYP2C9
SCHEMBL5148747 0.74 PTGS2 (0.53) PTGS2PTGS1CYP1A2CYP3A4CYP2C9
SCHEMBL7876680 0.71 PTGS2 (0.51) PTGS2PTGS1NPSR1MAPTSMN1; SMN2
SCHEMBL3430532 0.71 SLC16A3 (0.62) CCKARSLC16A3SLC16A1MCTS1PPP1CA
SCHEMBL4873320 0.71 MAPK1 (0.43) PTGS2SMN1; SMN2POLBMEN1KMT2A
SCHEMBL5148678 0.70 PTGS2 (0.44) PTGS2PTGS1CYP1A2CYP3A4CYP2C9
SCHEMBL451684 0.69 STS (0.47) PTGS2PTGS1CYP3A4
SCHEMBL6053761 0.69 PPP1CA (0.67) CCKARPPP1CAMALT1SMN1; SMN2RPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104903316-A Substituted pyrazoles as N-type calcium channel blockers JANSSEN PHARMACEUTICA NV 2015-09-09 CN disclosed